T3 Defense Registers Resale of 7.05M Shares From February 2026 Private Placement
DFNS is trading near its 52-week low of $3.7 (12% above the low) on light trading volume (0.1× avg).
Summary
T3 Defense registered 7,051,799 shares for resale by Esousa and other selling stockholders from its February 2026 private placement — a large overhang the company says could equal about 68% of shares outstanding after issuance, with no proceeds to the company from the resales.
Key Events · Financing and Capital Events · DFNS
-
7.05M Shares Registered for Resale
The prospectus covers 1,980,198 Conversion Shares from Series B Preferred and 5,071,601 Warrant Shares from Common Warrants issued in the February 2026 private placement with Esousa.
-
Overhang Equals ~68% of Post-Issuance Shares
According to the filing, the 7,051,799 shares would represent approximately 68% of outstanding shares after issuance, based on 3,250,296 shares outstanding at September 30, 2026.
-
Warrant Strike Far Above Market
Common Warrants carry a $266.25 exercise price versus a $5.05 closing price on October 22, 2026, so the company is unlikely to collect the roughly $15 million it would receive only if all warrants were exercised for cash.
-
Anti-Dilution Ratchet With No Floor
The Series B Conversion Price resets lower on below-price issuances with no specified floor, while the warrant exercise price has a $0.01 floor — a structure the filing itself describes as potentially self-reinforcing dilution.
Analysis · DFNS · Trade & Services
This 424B3 puts hard numbers on the Esousa private placement overhang: 7,051,799 shares are now registered for resale, which the filing itself says would represent roughly 68% of the post-issuance share count against 3,250,296 shares outstanding at September 30, 2026. No proceeds flow to the company from the resale — only from any cash exercise of the Common Warrants, which carry a $266.25 strike versus a $5.05 closing price on October 22, 2026. Cash exercise is therefore effectively off the table, and the warrants are more likely to be cashed out via the Black-Scholes cashless mechanism. Meanwhile, the Series B conversion price carries price-based anti-dilution with no floor, so a falling stock price mechanically increases the share count. All of this lands against a backdrop of a Nasdaq stockholders' equity deficiency notice received August 20, 2026 and a going-concern disclosure in the Q2 10-Q.
How filings like this one have moved
In the 30 days to Oct 23, 2026, 29.4% of the 1556 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DFNS was trading at $4.15 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $14M. The 52-week trading range was $3.70 to $1,087.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.